PERFORMANCE BASED STOCK OPTION GRANT AGREEMENTPerformance Based Stock Option Grant Agreement • November 7th, 2018 • CDK Global, Inc. • Services-business services, nec • Delaware
Contract Type FiledNovember 7th, 2018 Company Industry JurisdictionCDK GLOBAL, INC. (the “Company”), pursuant to the 2014 Omnibus Award Plan (the “Plan”), hereby irrevocably grants [PARTICIPANT NAME] (the “Participant”) on [GRANT DATE] the right and option to purchase [NUMBER OF AWARDS GRANTED] shares of the Common Stock, par value $0.01 per share, of the Company subject to the restrictions, terms and conditions herein.
PERFORMANCE-BASED STOCK OPTION GRANT AGREEMENT UNDER THE NPS PHARMACEUTICALS, INC. 1998 STOCK OPTION PLANPerformance-Based Stock Option Grant Agreement • March 16th, 2009 • NPS Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMarch 16th, 2009 Company Industry JurisdictionTHIS STOCK OPTION GRANT AGREEMENT (this "Option Agreement") evidences the grant, effective as of the above Grant Date, by NPS Pharmaceuticals, Inc., a Delaware corporation (the "Company") to the above-named Optionee, an employee of the Company, of an option to purchase ("Option") the above-listed number of shares (the "Optioned Shares") of the Company's common stock, par value $.001 per share ("Common Stock"), under and pursuant to the Company's 1998 Stock Option Plan, as amended (the "Plan") at the Exercise Price per Optioned Share set forth above. Capitalized terms used but not defined herein shall have the meaning given such terms in the Plan.